DETERMINATION OF IMMUNOREACTIVE FRACTION AND KINETIC-PARAMETERS OF A RADIOLABELED MONOCLONAL-ANTIBODY IN THE ABSENCE OF ANTIGEN EXCESS

被引:13
作者
DUX, R [1 ]
KINDLERROHRBORN, A [1 ]
LENNARTZ, K [1 ]
RAJEWSKY, MF [1 ]
机构
[1] UNIV ESSEN GESAMTHSCH,SCH MED,W GERMAN CANC CTR,INST CELL BIOL CANC RES,W-4300 ESSEN 1,GERMANY
关键词
MONOCLONAL ANTIBODY; CELL SURFACE ANTIGEN; IMMUNOREACTIVE FRACTION; KINETIC PARAMETER;
D O I
10.1016/0022-1759(91)90084-S
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Monoclonal antibodies (Mabs) directed against cell surface determinants and conjugated to fluorochromes, radionuclides or drugs are of increasing importance in cell and tumor biology as well as in clinical oncology. Many of the applications of Mab require precise and quantitative information regarding the molecular interactions of labeled antibody with the respective antigen expressed on the cell surface. These interactions are characterized by the association rate constant (k(a)), the dissociation rate constant (k(d)) and the antibody affinity constant (K). The immunoreactive fraction (IRF) of the labeled antibody molecules directly influences these parameters. IRF is usually reduced below 100% by antibody purification and labeling procedures and, in case of radiolabeled antibodies, by radiation damage during antibody storage. Besides the calculation of kinetic parameters, IRF should, therefore, be determined for the quality control of any antibody preparation before experimental or clinical application. Commonly used methods for measuring IRF are based on radioimmunoassays (RIA) on intact cells performed under antigen excess. However, especially with Mabs directed against cell surface antigens expressed in small numbers per cell and for displaying low affinity constants, these assays often give unsatisfactory results. We have, therefore, established a method which permits us to determine IRF, k(a)., k(d) and K for an I-125-labeled Mab with precision even in the absence of antigen excess.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 16 条
  • [1] MONOCLONAL-ANTIBODY IMMUNOCONJUGATES FOR CANCER-TREATMENT
    BALDWIN, RW
    BYERS, VS
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1989, 1 (05) : 891 - 894
  • [2] BERZOFSKY JA, 1984, FUNDAMENTAL IMMUNOLO, P611
  • [3] LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY
    BOLTON, AE
    HUNTER, WM
    [J]. BIOCHEMICAL JOURNAL, 1973, 133 (03) : 529 - 538
  • [4] CALIBRATION OF FLUORESCENCE INTENSITIES TO QUANTIFY ANTIBODY-BINDING SURFACE DETERMINANTS OF CELL SUBPOPULATIONS BY FLOW-CYTOMETRY
    DUX, R
    KINDLERROHRBORN, A
    LENNARTZ, K
    RAJEWSKY, MF
    [J]. CYTOMETRY, 1991, 12 (05): : 422 - 428
  • [5] STUDIES ON GROWTH STIMULATING ACTIVITY OF CALF SERUM ON CULTURES OF EMBRYONIC RAT CELLS
    FRANK, W
    SCHWALB, S
    RISTOW, HJ
    [J]. EXPERIMENTAL CELL RESEARCH, 1972, 70 (02) : 390 - &
  • [6] HAAS W, 1987, TUMOR HDB, P5
  • [7] EXPRESSION OF MONOCLONAL-ANTIBODY DEFINED CELL-SURFACE ANTIGENS DURING RAT-BRAIN DEVELOPMENT
    KINDLERROHRBORN, A
    AHRENS, O
    LIEPELT, U
    RAJEWSKY, MF
    [J]. DIFFERENTIATION, 1985, 30 (01) : 53 - 60
  • [8] KOSMAS C, 1989, DRUGS, V38, P4
  • [9] PHENOTYPIC PROPERTIES OF NEOPLASTIC CELL LINES DEVELOPED FROM FETAL RAT-BRAIN CELLS IN CULTURE AFTER EXPOSURE TO ETHYLNITROSOUREA INVIVO
    LAERUM, OD
    RAJEWSKY, MF
    SCHACHNER, M
    STAVROU, D
    HAGLID, KG
    HAUGEN, A
    [J]. ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1977, 89 (03): : 273 - 295
  • [10] NEOPLASTIC TRANSFORMATION OF FETAL RAT-BRAIN CELLS IN CULTURE AFTER EXPOSURE TO ETHYLNITROSOUREA INVIVO
    LAERUM, OD
    RAJEWSKY, MF
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (05) : 1177 - 1187